Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Physical examination, Pyrexia
Clinical narrative: I have a large bruise on my left arm at injection site; There were still a slight discoloration at the injection site; I had a normal reaction of chills, 100.6 temp, tired and achy starting 18 hours after 2nd dose, lasting 1.5 days, and a sore arm at the injection site for over a week.I have a large bruise on my left; I had a normal reaction of chills, 100.6 temp, tired and achy starting 18 hours after 2nd dose, lasting 1.5 days, and a sore arm at the injection site for over a week.I have a large bruise on my left; I had a normal reaction of chills, 100.6 temp, tired and achy starting 18 hours after 2nd dose, lasting 1.5 days, and a sore arm at the injection site for over a week.I have a large bruise on my left; I had a normal reaction of chills, 100.6 temp, tired and achy starting 18 hours after 2nd dose, lasting 1.5 days, and a sore arm at the injection site for over a week.I have a large bruise on my left; I had a normal reaction of chills, 100.6 temp, tired and achy starting 18 hours after 2nd dose, lasting 1.5 days, and a sore arm at the injection site for over a week.I have a large bruise on my left; Rash/localized rash at injection site; This is a spontaneous report from a contactable consumer or other non-HCP (patient herself). A 69-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EN6205) via an unspecified route of administration in left arm on 09Mar2021 18:45 as dose 2, single (at the age of 69-years-old) for COVID-19 immunization. Patient did not have Covid prior to vaccination. Patient was tested for COVID-19 post vaccination. Patient was not pregnant at the time of vaccination. Patient medical history included cardiovascular disease. Patient had not known allergies. The concomitant medications included Spironolactone tablet, levothyroxine sodium, rosuvatstain. The reported seriousness of the report was non-serious. Historical vaccine included BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EL1283) via an unspecified route of administration in right arm on 16Feb2021 11:30 as dose 1, single for COVID-19 immunization. Patient did not receive any other vaccine in last four weeks. Patient had a normal reaction of chills, 100.6 temp, tired and achy starting 18 hours after second dose, lasting 1.5 days, and a sore arm at the injection site for over a week on 17Mar2021 12:00. She had a large bruise on her left arm at injection site, about 3.25-inch diameter on 22Mar2021. Today at thirteenth day post second shot, there were still a slight discoloration at the injection site, but greatly faded on 22Mar2021. An urgent care P.A. on 14Mar2021 said the rash was cellulitis, prescribed Cephalexin 500mg and said to go to a hospital ER if the arm got worse, fever or streaking as it could be systemic and very serious. She almost had to reschedule a 17Mar2021 heart procedure due to uncertainty of the rash. A doctor called her later in the day of 14Mar2021 and thought it was not cellulitis based on her responses to her questions, and no need for antibiotics, so she did not take them. She asked was her 2 week localized rash at injection site normal. Why was this rash not seen as a normal side effect, and why leap to call it cellulitis, and maybe hospitalization. The adverse events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care visit. Patient received treatment for vaccination site rash at hospital while for the other events did not receive any treatment. Patient lab tests and procedures included SARS-COV-2RNA (nasal swab) test with result as negative on 14Mar2021. The outcome of the events vaccination site bruising, vaccination site rash and vaccination site discolouration was unknown while for the other events was recovering.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.